UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (986) 986
lomustine - administration & dosage (944) 944
male (758) 758
female (720) 720
antineoplastic combined chemotherapy protocols - therapeutic use (627) 627
middle aged (558) 558
adult (533) 533
vincristine - administration & dosage (481) 481
life sciences & biomedicine (480) 480
science & technology (480) 480
aged (397) 397
procarbazine - administration & dosage (330) 330
oncology (329) 329
cyclophosphamide - administration & dosage (306) 306
combined modality therapy (257) 257
brain neoplasms - drug therapy (245) 245
adolescent (230) 230
doxorubicin - administration & dosage (230) 230
lomustine - therapeutic use (221) 221
chemotherapy (218) 218
drug therapy, combination (199) 199
antineoplastic combined chemotherapy protocols - adverse effects (198) 198
animals (190) 190
lung neoplasms - drug therapy (188) 188
treatment outcome (186) 186
methotrexate - administration & dosage (178) 178
lomustine - adverse effects (164) 164
prognosis (163) 163
lomustine (155) 155
abridged index medicus (152) 152
antineoplastic agents - administration & dosage (145) 145
prednisone - administration & dosage (144) 144
antineoplastic combined chemotherapy protocols - administration & dosage (141) 141
drug administration schedule (138) 138
etoposide - administration & dosage (136) 136
dacarbazine - administration & dosage (132) 132
cisplatin - administration & dosage (131) 131
clinical trials as topic (130) 130
bleomycin - administration & dosage (125) 125
hodgkin disease - drug therapy (124) 124
time factors (120) 120
child (118) 118
carcinoma, small cell - drug therapy (110) 110
survival analysis (107) 107
vinblastine - administration & dosage (107) 107
follow-up studies (105) 105
brain neoplasms - radiotherapy (103) 103
retrospective studies (103) 103
cancer (102) 102
neoplasm staging (102) 102
survival rate (102) 102
neurosciences & neurology (96) 96
child, preschool (93) 93
clinical neurology (93) 93
brain neoplasms - pathology (91) 91
disease-free survival (91) 91
glioma - drug therapy (88) 88
prospective studies (84) 84
mice (81) 81
glioblastoma - drug therapy (80) 80
antineoplastic agents - therapeutic use (78) 78
lung neoplasms - mortality (76) 76
dose-response relationship, drug (75) 75
remission induction (75) 75
chemotherapy, adjuvant (74) 74
neoplasm recurrence, local - drug therapy (74) 74
radiotherapy (71) 71
brain neoplasms - mortality (70) 70
fluorouracil - administration & dosage (70) 70
melanoma - drug therapy (69) 69
brain neoplasms - therapy (67) 67
nitrosourea compounds - administration & dosage (67) 67
antineoplastic agents, alkylating - administration & dosage (63) 63
radiotherapy dosage (62) 62
antineoplastic agents, alkylating - therapeutic use (60) 60
carmustine - administration & dosage (60) 60
random allocation (60) 60
veterinary sciences (58) 58
astrocytoma - drug therapy (57) 57
dacarbazine - analogs & derivatives (57) 57
medicine & public health (57) 57
vincristine - therapeutic use (55) 55
administration, oral (54) 54
dogs (54) 54
lung neoplasms - radiotherapy (54) 54
mechlorethamine - administration & dosage (54) 54
care and treatment (53) 53
adenocarcinoma - drug therapy (52) 52
cytarabine - administration & dosage (52) 52
neoplasm metastasis (52) 52
carcinoma, small cell - mortality (51) 51
hodgkin disease - radiotherapy (51) 51
lomustine - pharmacology (51) 51
nitrosourea compounds - therapeutic use (51) 51
vincristine - adverse effects (51) 51
cyclophosphamide - therapeutic use (50) 50
drug evaluation (50) 50
oligodendroglioma - drug therapy (50) 50
antineoplastic agents - adverse effects (49) 49
ccnu (49) 49
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1080) 1080
Russian (39) 39
French (38) 38
German (29) 29
Polish (19) 19
Japanese (9) 9
Chinese (8) 8
Spanish (8) 8
Italian (5) 5
Croatian (1) 1
Czech (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical oncology, ISSN 1527-7755, 12/2005, Volume 23, Issue 36, pp. 9198 - 9207
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 12/2009, Volume 27, Issue 35, pp. 5874 - 5880
Purpose The standard of care for anaplastic gliomas is surgery followed by radiotherapy. The NOA-04 phase III trial compared efficacy and safety of... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Procarbazine - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lomustine - adverse effects | Middle Aged | Brain Neoplasms - pathology | DNA Repair Enzymes - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Alkylating - administration & dosage | Glioma - radiotherapy | Glioma - genetics | Young Adult | DNA Methylation | Time Factors | Radiotherapy, Adjuvant - adverse effects | Glioma - pathology | Treatment Failure | Tumor Suppressor Proteins - genetics | Dacarbazine - analogs & derivatives | Vincristine - administration & dosage | Adult | Female | Brain Neoplasms - mortality | Chemotherapy, Adjuvant | Brain Neoplasms - radiotherapy | Promoter Regions, Genetic | Dacarbazine - administration & dosage | Glioma - mortality | Drug Administration Schedule | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Brain Neoplasms - drug therapy | Disease Progression | Disease-Free Survival | DNA Modification Methylases - genetics | Procarbazine - adverse effects | Vincristine - adverse effects | Aged | Mutation | Antineoplastic Agents, Alkylating - adverse effects | Lomustine - administration & dosage | Glioma - drug therapy | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 04/2016, Volume 34, Issue 11, pp. 1175 - 1181
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 10/2010, Volume 28, Issue 30, pp. 4601 - 4608
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2003, Volume 21, Issue 14, pp. 2726 - 2731
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2016, Volume 374, Issue 14, pp. 1344 - 1355
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2017, Volume 377, Issue 20, pp. 1954 - 1963
The addition of bevacizumab to lomustine in patients with recurrent glioblastoma failed to increase overall survival but was associated with a small increase... 
Medicine(all) | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bevacizumab - administration & dosage | Bevacizumab - adverse effects | Humans | Lomustine - adverse effects | Middle Aged | Kaplan-Meier Estimate | Male | Antineoplastic Agents, Alkylating - administration & dosage | Brain Neoplasms - drug therapy | Chemoradiotherapy | Glioblastoma - radiotherapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Aged, 80 and over | Adult | Female | Aged | Brain Neoplasms - mortality | Antineoplastic Agents, Alkylating - adverse effects | Brain Neoplasms - radiotherapy | Glioblastoma - drug therapy | Glioblastoma - mortality | Lomustine - administration & dosage | Patient outcomes | Lomustine | Outcome and process assessment (Health Care) | Dosage and administration | Research | Drug therapy | Glioblastoma multiforme | Methods | Medical research | Nuclear magnetic resonance--NMR | Brain cancer | Methylguanine | Glioblastoma | Clinical trials | Oncology | Cognition | Cancer therapies | Survival | Quality of life | Bevacizumab | O6-methylguanine-DNA methyltransferase | Studies | Brain research | DNA methylation | DNA methyltransferase | Cancer | Index Medicus | Abridged Index Medicus | Life Sciences
Journal Article